Neuromyelitis optica (NMOSD): vizsgálatok itt: Egyesült Királyság
4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Where
- London
- Életkor
- 2 év to 11 év
- People
- 8 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05199688 · EU 2023-507817-85-00 - No phaseNot yet taking people in Egyesült KirályságEarly Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool
- Where
- London
- Életkor
- 16 év and over
- People
- 180
- Run by
- King's College London
See details and how to joinNCT07704294 - No phaseTaking peopleStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- London
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644 - 2. fázisTaking peopleStudy of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
- Where
- Birmingham, London
- Életkor
- 2 év to 17 év
- People
- 15 worldwide
- Run by
- Amgen
See details and how to joinNCT05549258 · EU 2023-510007-22-00